MS170 is a potent AKT-directed PROTAC degrader described as a selective compound capable of reducing total cellular AKT protein. Public product summaries report binding to AKT isoforms and identify the molecule as a PROTAC AKT degrader, although they do not fully disclose a co-crystal-defined binding site or complete ternary-complex structure. In PROTAC design, MS170 serves as a bifunctional molecule in which an AKT-recognition ligand is connected to a ubiquitin-ligase recruiter through a linker optimized for productive degradation. Its main function is to convert AKT engagement into ubiquitin-proteasome-mediated protein removal, enabling researchers to distinguish kinase inhibition from loss of AKT scaffold and signaling functions. MS170 is useful in PI3K–AKT pathway research, degrader potency benchmarking, isoform engagement studies, resistance-mechanism analysis, and comparative optimization of AKT-directed degrader chemotypes.
Structure of 2376136-61-5
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Target: MS170 targets pan-AKT kinases, including AKT1, AKT2, and AKT3 isoforms.
Binding site: Its AKT-binding warhead occupies the ATP-competitive catalytic site of AKT kinases.
Mechanism of action: MS170 is a CRBN-recruiting AKT PROTAC developed to promote robust degradation of total AKT through the ubiquitin-proteasome system. By linking an AKT-directed ligand to a cereblon-binding moiety, MS170 induces proximity between AKT isoforms and the CRL4CRBN E3 ligase complex, driving polyubiquitination and subsequent proteasomal clearance. This degradation mechanism enables sustained pathway modulation beyond occupancy-based inhibition. MS170 is especially valuable for studying AKT dependency, downstream signaling attenuation, degradation selectivity, and cellular responses where removal of AKT protein provides clearer mechanistic resolution than catalytic blockade alone.
Applications• PROTAC-Mediated Kinase Degradation: MS170 is utilized to selectively degrade specific kinases, enabling researchers to study the role of these enzymes in cellular signaling pathways. By targeting kinases for degradation, MS170 facilitates the investigation of kinase-dependent processes and aids in the discovery of novel therapeutic targets.
• Targeted Oncoprotein Degradation: MS170 is applied in cancer research to degrade oncogenic proteins, offering insights into tumor biology and potential treatment strategies. This approach allows for the exploration of protein function and the assessment of degradation efficacy in oncogenic pathways.
• E3 Ligase Recruitment Studies: MS170 provides a platform for studying the recruitment and engagement of E3 ligases in the ubiquitin-proteasome system. Through its structure, researchers can examine the efficiency and specificity of E3 ligases in targeted protein degradation, enhancing our understanding of this crucial cellular process.
• Mechanistic Studies of Protein Degradation: MS170 serves as a valuable tool for elucidating the mechanisms underlying targeted protein degradation. By employing this PROTAC, scientists can dissect the steps involved in the ubiquitination and subsequent proteasomal degradation of target proteins, contributing to the development of more effective degradation strategies.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.